Massaia M - Search Results

1

Intermediate-dose melphalan (100 mg/m2)/bortezomib/thalidomide/dexamethasone and stem cell support in patients with refractory or relapsed myeloma.

Palumbo A, Avonto I, Bruno B, Falcone A, Scalzulli PR, Ambrosini MT, Bringhen S, Gay F, Rus C, Cavallo F, Falco P, Massaia M, Musto P, Boccadoro M. Palumbo A, et al. Among authors: massaia m. Clin Lymphoma Myeloma. 2006 May;6(6):475-7. doi: 10.3816/CLM.2006.n.028. Clin Lymphoma Myeloma. 2006. PMID: 16796778 Clinical Trial.

2

Cyclosporin A and dipyridamole: an effective combination against the generation of cytotoxic T lymphocytes (CTL).

Massaia M, Bianchi A, Attisano C, Dianzani U, Boccadoro M, Pileri A. Massaia M, et al. Pharmacol Res. 1992 Sep;26 Suppl 2:12-3. doi: 10.1016/1043-6618(92)90576-w. Pharmacol Res. 1992. PMID: 1409272 No abstract available.

3

[Multiple myeloma. Mechanisms of proliferation and neoplastic progression and their clinical implications].

Boccadoro M, Battaglio S, Dianzani U, Frieri R, Gallone G, Massaia M, Omedè P, Palumbo A, Pileri A. Boccadoro M, et al. Among authors: massaia m. Haematologica. 1991 Jun;76 Suppl 3:100-6. Haematologica. 1991. PMID: 1752506 Review. Italian. No abstract available.

4

Phenotypic and functional analysis of peripheral blood lymphocytes during interferon-alpha 2b therapy in multiple myeloma patients with low tumor mass.

Bianchi A, Omedé P, Attisano C, Camponi A, Dianzani U, Boccadoro M, Pileri A, Massaia M. Bianchi A, et al. Among authors: massaia m. Haematologica. 1991 Sep-Oct;76(5):383-8. Haematologica. 1991. PMID: 1806441

5

Dipyridamole in vitro suppresses the generation of T-cell cytotoxic functions: synergistic activity with cyclosporine.

Massaia M, Bianchi A, Attisano C, Dianzani U, Boccadoro M, Pileri A. Massaia M, et al. Eur J Haematol. 1991 Jan;46(1):6-10. doi: 10.1111/j.1600-0609.1991.tb00506.x. Eur J Haematol. 1991. PMID: 1988314

6

Defective interleukin-2 induction of lymphokine-activated killer (LAK) activity in peripheral blood T lymphocytes of patients with monoclonal gammopathies.

Massaia M, Bianchi A, Dianzani U, Camponi A, Attisano C, Boccadoro M, Pileri A. Massaia M, et al. Clin Exp Immunol. 1990 Jan;79(1):100-4. doi: 10.1111/j.1365-2249.1990.tb05134.x. Clin Exp Immunol. 1990. PMID: 2105868 Free PMC article.

7

Multiple myeloma: altered CD4/CD8 ratio in bone marrow.

Redoglia V, Boccadoro M, Battaglio S, Dianzani U, Massaia M, Pileri A. Redoglia V, et al. Among authors: massaia m. Haematologica. 1990 Mar-Apr;75(2):129-31. Haematologica. 1990. PMID: 2113506

8

Multiple myeloma: beta-2-microglobulin is not a useful follow-up parameter.

Boccadoro M, Omedè P, Frieri R, Battaglio S, Gallone G, Massaia M, Redoglia V, Pileri A. Boccadoro M, et al. Among authors: massaia m. Acta Haematol. 1989;82(3):122-5. doi: 10.1159/000205322. Acta Haematol. 1989. PMID: 2510433

9

[Prognostic factors in multiple myeloma].

Boccadoro M, Bianchi A, Dianzani U, Frieri R, Gallone G, Massaia M, Omede P, Palumbo A, Pileri A. Boccadoro M, et al. Among authors: massaia m. Haematologica. 1989 Oct;74(5 Suppl):347-57. Haematologica. 1989. PMID: 2512219 Review. Italian. No abstract available.

10

Altered expression of growth-regulated protooncogenes in human malignant plasma cells.

Palumbo AP, Pileri A, Dianzani U, Massaia M, Boccadoro M, Calabretta B. Palumbo AP, et al. Among authors: massaia m. Cancer Res. 1989 Sep 1;49(17):4701-4. Cancer Res. 1989. PMID: 2667753

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

196 results

Search Page

Filters